Ohio medical marijuana companies spend thousands on real estate while awaiting licenses, Missouri MMJ businesses eye ballot measures that would prove most business-friendly, and Oregon’s top federal prosecutor calls out the state’s excess cannabis output.
Bart Schaneman
Bart Schaneman's Latest Posts
Benefits of due diligence: Q&A with GB Sciences CEO John Poss
John Poss is a self-described rough-water sailor who has made a career of righting the ship for sinking companies.
With three decades of experience consulting for companies undergoing major upheavals, he decided three years ago to dive into the cannabis industry.
Since then, as CEO of Las Vegas-based cannabis company GB Sciences, Poss has partnered with universities in the United States and abroad.
Ohio delays awarding medical cannabis dispensary licenses
Ohio medical marijuana dispensary applicants will have to wait until June, at the earliest, to find out if they will be licensed, even though applications have been scored.
Oregon’s US attorney ‘frustrated’ with state’s cannabis overproduction
The top federal prosecutor in Oregon is taking aim at the state's overproduction of marijuana. Billy Williams, the U.S. attorney for Oregon, issued guidelines for cannabis enforcement in response to the Justice Department's decision to rescind...
Week in Review: Medical marijuana research, Louisiana lawsuit & Ohio’s extra MMJ license
Pennsylvania approves eight universities to conduct medical marijuana research, a company spurned for a Louisiana license sues the state, and Ohio awards an additional MMJ permit.
Here’s a closer look at some notable developments in the cannabis industry over the past week.
Ohio awards medical marijuana grow license after resolving error in process
Trying to rectify an application scoring error, Ohio regulators issued a medical marijuana cultivation license to Illinois-based PharmaCann Ohio, which had been rejected in the original round of license review. According to the Cleveland Plain...
Eight Pennsylvania colleges get OK to study medical marijuana
Pennsylvania on Monday unveiled eight universities that will be allowed to research medical marijuana, a potential boon for an industry where cannabis study is extremely limited.
Week in Review: Marijuana vs. alcohol, CA’s lagging cannabis tax revenue & Utah MMJ ally
State-legal cannabis users consume less liquor and medications, according to a report, California isn't fetching as much marijuana tax revenue as anticipated, and Utah's MMJ campaign gains a key supporter. Here’s a closer look at some notable developments in the...
Colorado ready to add autism to medical cannabis qualifying conditions
A bill that would add autism spectrum disorder to Colorado's list of conditions that can be treated with medical marijuana is headed to Gov. John Hickenlooper's desk. The state's General Assembly easily passed HB 1263 on May 4, Denver...
Florida to closely monitor medical cannabis edibles production facilities
Florida plans to regulate medical marijuana edibles as it does other food products. The state's Department of Agriculture and Consumer Services said cannabis producers will be subject to random inspections to ensure edibles are being made in facilities that meet...
Michigan regulator to consider expanding medical cannabis conditions list
A top Michigan regulator will consider an advisory board's recommendation to add chronic pain, autism and other conditions to a list of allowable medical conditions for the use of marijuana. The review panel recommended including the following conditions: Obsessive...
Dallas marijuana investment firm starts $50 million fund
Dallas-based marijuana investment firm Cresco Capital Partners has launched a second fund and plans to raise $50 million to pump into cannabis companies. Cresco Managing Partner Matt Hawkins said the firm has raised $10 million to date,...










